[Primary hypoparathyroidism resistant to treatment with vitamin D3, 25-hydroxycholecalciferol and dihydrotachysterol. Efficacy of treatment with 1 alpha,25-dihyroxycholecalciferol].
D002112:Calcifediol / Q000627:therapeutic use; D002117:Calcitriol / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000627:therapeutic use; D004097:Dihydrotachysterol / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007011:Hypoparathyroidism / Q000188:drug therapy*; D008875:Middle Aged
D002762:Cholecalciferol; D002117:Calcitriol; D002112:Calcifediol; D004097:Dihydrotachysterol
Hipoparatiroidismo primario resistente al tratamiento con vitamina D3, 25-hidroxicolecalciferol y dihidrotaquisterol. Eficacia del tratamiento con 1 alpha, 25-dihidroxicolecalciferol.